Peptazole E.C. Tab 20mg | Antacids, Antireflux Agents & Antiulcerants | Pharmaceuticals | Products

Peptazole E.C. Tab 20mg

Code:

DRPS0039A

Active Ingredient:

Pantoprazole Na Sesquihydrate 20mg

Description:

Yellow oval enteric coated tablet imprinted "HL 20" on one side.

Regulatory Class:

P1S1S3
Prescription Drug

HK-61595

Indication
Indication
Use and Administration

Indication

Use and Administration

Treatment of mild GERD & associated symptoms. Long-term management & prevention of relapse in reflux oesophagitis. Prevention of gastroduodenal ulcers induced by nonselective NSAIDs in patients at risk w/ a need for continuous NSAID treatment. Eradication of H. pylori. Duodenal ulcer, gastric ulcer & reflux esophagitis. Zollinger-Ellison syndrome & other pathological hypersecretory conditions.

Tab Treatment of mild GERD & associated symptoms 1 tab (20 mg)/day. Long-term management & prevention of relapse in reflux oesophagitis 1 tab (20 mg)/day, increased to 40 mg/day if a relapse occurs. Prevention of gastroduodenal ulcers induced by nonselective NSAIDs in patients at risk w/ a need for continuous NSAID treatment 1 tab (20 mg)/day. Eradication of H. pylori 1 tab (40 mg) bd w/ combination of amoxicillin 1,000 mg bd & clarithromycin 500 mg bd or metronidazole 500 mg bd & clarithromycin 500 mg bd or amoxicillin 1,000 mg bd & metronidazole 500 mg bd. Duodenal ulcer, gastric ulcer & reflux esophagitis 1 tab (40 mg) daily for 4 wk, may be increased to 2 tab daily. Zollinger-Ellison syndrome & other pathological hypersecretory conditions Initially 80 mg daily & should be adapted according to clinical needs.
Should be taken on an empty stomach: Take 1 hr before meals. Swallow whole, do not chew/crush.